Equity Profile
Pre-Earnings Brief
ICON PLC is a leading provider of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. Operating in the Health Care sector, the company plays a crucial role in advancing drug development and clinical trials, which are vital for bringing new therapies to market.
EPS
Earnings per share is a key indicator of the company's profitability and financial health.
Revenue
Revenue figures provide insight into the company's sales performance and market demand.
Wall Street expectations, options signals, track record, and call prep available with Pro.
EPS Beat Streak
4Q
EPS Beat Rate
88%
Avg EPS Surprise
+3.85%
Avg Stock Reaction
+0.85%
In Q3-2025, ICON PLC reported an EPS of $3.31, surpassing estimates by 5.41%. However, revenue details were not disclosed, and the stock saw a slight decline the following day.
Management Promises & Guidance
Analysts expect ICON PLC to report solid earnings, with a consensus EPS of $3.19. The company has a strong track record of beating earnings estimates, which could lead to positive market reactions.
Bull Case
If ICON exceeds EPS expectations and demonstrates strong revenue growth, it could signal robust demand for its services, boosting investor confidence.
Bear Case
Conversely, if the company fails to meet EPS estimates or provides weak guidance, it could raise concerns about its growth trajectory and lead to a decline in stock price.
EPS
$3.19Earnings per share is a key indicator of the company's profitability and financial health.
Revenue
$2.0BRevenue figures provide insight into the company's sales performance and market demand.
Expectations
The print will turn on these two things.
Q1
Will EPS exceed the consensus estimate of $3.19?
A beat on EPS would reinforce ICON's strong performance history and could lead to a positive stock reaction.
Q2
What guidance will management provide for future revenue growth?
Clear guidance on revenue growth is crucial for investor confidence, especially in a competitive market.
Edge
Why consensus could be wrong
The Street may underestimate ICON's ability to leverage its recent investments in technology and operational efficiency, which could lead to higher-than-expected margins.
Supporting Evidence
ICON has consistently beaten EPS estimates in recent quarters, indicating strong operational execution.
The options market is pricing a larger move than historical averages, suggesting potential for a significant surprise.
Key Risk
If revenue growth exceeds $2.0B, it could challenge the current consensus and shift market sentiment.
Edge
Pre-commit to what would confirm each case.
The market is debating whether ICON can sustain its growth trajectory amid increasing competition and economic pressures.
Bull Confirmed If
An EPS of $3.25 or higher would confirm strong operational performance and growth potential.
Bear Confirmed If
An EPS below $3.00 would raise concerns about the company's profitability and market position.
Pre-Earnings Positioning
Implied Move
±4.0%
Historical Avg
±1.2%
The options market is pricing in a potential move of about 4% following the earnings report, indicating some uncertainty among investors.
Options are pricing ±4.0% while ICLR has averaged ±1.2% over the last 8 prints — setup is pricing rich.
30d HV
44.7%
Edge
Cross-company pattern from 30 similar setups.
Prior-quarter beat + options rich in Health Care
n=30Fade rate: 7 of 20 (35%)
This setup has occurred 30 times across Health Care in the last 2 years. 13 of 20 (65%) held or extended their move within 5 days — this setup typically holds direction. The average absolute 1-day move is 5.8%, with a raw directional average of +2.2% (modestly positive historical bias).
Preparation
Likely market behavior by outcome — not investment advice.
Beat & Raise
If ICON beats expectations, history suggests a potential stock increase of around +1.10%, confirming bullish sentiment.
In-Line / Cautious
If results are in line with expectations, the stock may experience muted movement as investors await further guidance.
Miss
A miss could lead to a decline of about -0.96%, reflecting disappointment in the company's performance.
Preparation
House & Senate STOCK Act disclosures over the trailing 6 months.
Trades
2
0 buys·2 sells
Members
2
House only
Est. Notional
$101,002.00–$265,000.00
disclosed dollar ranges
Most Active Members
1 trade
Net selling
1 trade
Net selling
Recent Transactions
Traded Mar 5, 2026 · disclosed Apr 3, 2026
$100,001.00–$250,000.00
Traded Feb 12, 2026 · disclosed Mar 12, 2026
$1,001.00–$15,000.00
Filed 30–45+ days after the trade. Treat as positional context, not a leading indicator. Amounts are SEC-mandated dollar ranges, not exact values.
Preparation
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
DOMINOS PIZZA INC